The Breakthrough Immunotherapy and the Race to Cure Cancer

被引：2
|
作者：
Simpkins, Carolyn Wong [1 ]
机构：
[1] Hlth Syst & Data Technol & Hlth Care Org, Chevy Chase, MD 20815 USA
来源：
SCIENCE | 2018年 / 362卷 / 6420期
关键词：
D O I：
10.1126/science.aav6272
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：1254 / 1254
页数：1
相关论文
共 50 条
  • [41] The Breakthrough: Politics and Race in the Age of Obama
    McIlwain, Charlton
    QUALITATIVE SOCIOLOGY, 2012, 35 (02) : 229 - 235
  • [42] The hard questions - Race for the cure
    Glazer, N
    NEW REPUBLIC, 1996, 215 (15) : 29 - 29
  • [43] The Breakthrough: Politics and Race in the Age of Obama
    Burns, Ann
    LIBRARY JOURNAL, 2008, 133 (18) : 82 - +
  • [44] THE BREAKTHROUGH: Politics and Race In the Age of Obama
    Dixler, Elsa
    NEW YORK TIMES BOOK REVIEW, 2009, : 36 - 36
  • [45] THE BREAKTHROUGH Politics and Race in the Age of Obama
    Boynton, Robert S.
    NEW YORK TIMES BOOK REVIEW, 2009, : 11 - 11
  • [46] THE BREAKTHROUGH - THE RACE FOR THE SUPERCONDUCTOR - HAZEN,RM
    GARWIN, L
    NATURE, 1988, 334 (6182) : 479 - 480
  • [47] Lung resection and immunotherapy: two allied for a new hope in lung cancer cure
    Mennecier, Bertrand
    Olland, Anne
    Massard, Gilbert
    Falcoz, Pierre-Emmanuel
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S4168 - S4169
  • [48] HIV cure and cancer immunotherapy: cross-disciplinary research at its best
    Deeks, S.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [49] EFFECT OF ADJUVANT CHEMOTHERAPY OR IMMUNOTHERAPY ON THE PROGNOSIS OF COLORECTAL-CANCER OPERATED FOR CURE
    WUNDERLICH, M
    SCHIESSEL, R
    RAINER, H
    RAUHS, R
    KOVATS, E
    SCHEMPER, M
    DITTRICH, C
    MICKSCHE, M
    SEDLACEK, HH
    BRITISH JOURNAL OF SURGERY, 1985, 72 : S107 - S110
  • [50] The CD112R/CD112 axis: a breakthrough in cancer immunotherapy
    Zeng, Taofei
    Cao, Yuqing
    Jin, Tianqiang
    Tian, Yu
    Dai, Chaoliu
    Xu, Feng
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
12345